Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action

British Journal of Pharmacology
Sandra FredjRobert S Kass

Abstract

1 We studied the effects of ranolazine, an antianginal agent with promise as an antiarrhythmic drug, on wild-type (WT) and long QT syndrome variant 3 (LQT-3) mutant Na(+) channels expressed in human embryonic kidney (HEK) 293 cells and knock-in mouse cardiomyocytes and used site-directed mutagenesis to probe the site of action of the drug. 2 We find preferential ranolazine block of sustained vs peak Na(+) channel current for LQT-3 mutant (DeltaKPQ and Y1795C) channels (IC(50)=15 vs 135 microM) with similar results obtained in HEK 293 cells and knock-in myocytes. 3 Ranolazine block of both peak and sustained Na(+) channel current is significantly reduced by mutation (F1760A) of a single residue previously shown to contribute critically to the binding site for local anesthetic (LA) molecules in the Na(+) channel. 4 Ranolazine significantly decreases action potential duration (APD) at 50 and 90% repolarization by 23+/-5 and 27+/-3%, respectively, in DeltaKPQ mouse ventricular myocytes but has little effect on APD of WT myocytes. 5 Computational modeling of human cardiac myocyte electrical activity that incorporates our voltage-clamp data predicts marked ranolazine-induced APD shortening in cells expressing LQT-3 mutant channels. 6...Continue Reading

References

Aug 24, 1995·Nature·P B BennettA L George
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y QuW A Catterall
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S RagsdaleW A Catterall
Jul 1, 1996·Circulation Research·R H AnR S Kass
Apr 1, 1997·The Journal of Clinical Investigation·D W WangP B Bennett
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·N J LinfordW A Catterall
Dec 11, 1999·Circulation Research·C BezzinaA A Wilde
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·M R GralinskiB R Lucchesi
May 16, 2000·Circulation Research·M W VeldkampJ R Balser
Dec 29, 2000·Pediatric Clinics of North America·F Candotti
Jul 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·A C ZygmuntC Antzelevitch
Dec 14, 2001·Proceedings of the National Academy of Sciences of the United States of America·M MantegazzaT Scheuer
Nov 6, 2002·The Journal of Clinical Investigation·Colleen E ClancyRobert S Kass
Apr 16, 2003·Circulation·Colleen E ClancyRobert S Kass
Sep 23, 2003·The Journal of Biological Chemistry·Michihiro TateyamaRobert S Kass
Dec 6, 2003·American Journal of Physiology. Heart and Circulatory Physiology·K H W J ten TusscherA V Panfilov
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Bernard R ChaitmanUNKNOWN Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators
Jan 28, 2004·The Journal of General Physiology·Howard K MotoikeRobert S Kass
Mar 20, 2004·The Journal of Pharmacology and Experimental Therapeutics·Lin WuLuiz Belardinelli
Jul 10, 2004·Journal of Cardiovascular Pharmacology·Yejia SongLuiz Belardinelli
Sep 21, 2004·Journal of Cardiovascular Pharmacology and Therapeutics·Charles AntzelevitchGuillermo Perez

❮ Previous
Next ❯

Citations

Aug 16, 2008·Pflügers Archiv : European journal of physiology·M MilleK Hilber
Oct 31, 2012·Cardiovascular Drugs and Therapy·Alexander Burashnikov, Charles Antzelevitch
Mar 14, 2003·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·S LévyUNKNOWN Working Group on Arrhythmias, Working Group on Cardiac Pacing of the European Society of Cardiology, North American Society
Jan 30, 2010·Cardiovascular Research·Larissa FabritzPaulus Kirchhof
Jun 16, 2011·Cardiovascular Research·Marc D LemoineStanley Nattel
Dec 12, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Richard L VerrierLuiz Belardinelli
Feb 5, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Peter MilbergLars Eckardt
Mar 13, 2010·Current Opinion in Cardiology·Jonathan T Lu, Robert S Kass
Apr 12, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Norishige MoritaHrayr S Karagueuzian
Aug 9, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Andrew C ZygmuntCharles Antzelevitch
Nov 16, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Hai HuangMohamed Chahine
Sep 30, 2010·The Journal of Clinical Investigation·Kevin J Sampson, Robert S Kass
Jan 3, 2013·The Journal of Clinical Investigation·Alfred L George
Dec 27, 2011·Critical Reviews in Biomedical Engineering·Robert K Amanfu, Jeffrey J Saucerman
Oct 8, 2014·Paediatric Drugs·Alon BarsheshetIlan Goldenberg
Sep 8, 2011·Canadian Journal of Physiology and Pharmacology·Kirstine CalloeCharles Antzelevitch
Feb 1, 2013·American Journal of Physiology. Cell Physiology·W-S Vanessa HoIain A Greenwood
Apr 4, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Haruaki Nakaya
Mar 7, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Jørgen K KantersThomas Jespersen
Jun 21, 2015·Trends in Cardiovascular Medicine·Jonathan C Makielski
Aug 10, 2012·Channels·Arthur BeyderGianrico Farrugia
Mar 23, 2011·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Charles AntzelevitchLuiz Belardinelli
Jul 7, 2017·Journal of Biomolecular Structure & Dynamics·Xiaofeng JiShiyong Liu
Jun 15, 2017·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Rachel E CavesAndrew F James
Dec 16, 2016·Physiological Reviews·Christopher L-H Huang
Nov 4, 2016·Physiological Reviews·M S BohnenR S Kass
Feb 28, 2014·Clinical Medicine Insights. Therapeutics·Mohammed AldakkakAmadou K S Camara
May 30, 2015·Circulation. Arrhythmia and Electrophysiology·Franck PotetAlfred L George
Jul 31, 2013·Circulation Research·Jonathan D MorenoColleen E Clancy
Nov 11, 2014·F1000Research·Morgan ChevalierHugues Abriel
Dec 12, 2007·British Journal of Pharmacology·D A Saint
Dec 12, 2007·British Journal of Pharmacology·J C Shryock, L Belardinelli
Feb 28, 2018·Scientific Reports·Mena AbdelsayedPeter C Ruben
Aug 26, 2010·British Journal of Pharmacology·Kristopher M KahligAlfred L George
Mar 8, 2006·British Journal of Pharmacology·Jonathan C Makielski, Carmen R Valdivia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.